Other OTC - Delayed Quote • USD
Wuhan General Group (China), Inc. (WUHN)
At close: February 2 at 2:46 PM EST
Key Executives
Amounts are as of December 31, 2012 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Ms. Carol Pan | Principal Financial Officer, Principal Accounting Officer and Treasurer | 60k | -- | 1984 |
| Mr. Jeffrey Robinson | Founder, Chairman & CEO | -- | -- | -- |
| Mr. Willem Jonker | Chief Operating Officer | -- | -- | -- |
| Dr. Hyder Ali Khoja A.Ag., M.Sc., Ph.D. | Chief Scientific Officer | -- | -- | -- |
| Ms. Shivani Subudhi | Head of Marketing | -- | -- | -- |
| Mr. Huang Zhaoqi | Vice General Manager of Turbine and Director | -- | -- | 1962 |
| Dr. Anna Leralta Morera | Chief Medical Officer | -- | -- | -- |
| Mr. Samuel Williams | Head of Food Formulations & Functional Foods | -- | -- | -- |
| Ms. Clementine Toto | Head of African Aromatherapy | -- | -- | -- |
| Nicola Royce | Managing Director of M2Biome | -- | -- | -- |
Wuhan General Group (China), Inc.
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Full Time Employees:
- 700
Description
Wuhan General Group (China), Inc., through its subsidiaries, researches, develops, and commercializes a range of cannabidiol (CBD)-based products under the Dr. AnnaRx brand for pharmacies. It also focuses on exploring and developing other indications for psilocybin new therapies that will enable patients who suffer from mental illness. The company offers its products for medical applications, including cancer, mental disorders, chronic pain, and others. Wuhan General Group (China), Inc. is headquartered in Pointe-Claire, Canada.
Corporate Governance
Wuhan General Group (China), Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Recent Events
Recent Events Information Not Available
Upcoming Events
Upcoming Events Information Not Available